NCT07007078View on ClinicalTrials.gov

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acne Vulgaris
Interventions
DRUG

dihydroartemisinin

DHA 40mg tid for 90 days

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER